The malfunction of the JAK/STAT3 signaling pathway is associated with cancer development and may be a promising target for new treatment; thus, understanding the role of JAK/STAT3 inhibitors may be crucial to achieve a breakthrough in cancer therapy [65,66,67]. The gene discussed is STAT3; the disease is cancer.